All News

A phase 1/2 trial is examining the novel agent, SNS-101, with or without Libtayo for the treatment of patients with advanced solid cancers.

One doctor tells CURE why the FDA’s approval of the TKI Bosulif to treat children with chronic myelogenous leukemia “is really important.”

There are so many aspects of survivorship that I found myself unprepared for. One deeply personal aspect that caught me completely off guard goes back to my childhood.

Now in its fifth edition, “The Complete Guide to Breast Reconstruction: Choosing the Best Options After Your Mastectomy” by two-time breast cancer survivor Kathy Steligo offers patients comprehensive, up-to-date information.

Pomalyst plus Velcade with dexamethasone improves survival outcomes for patients with relapsed/refractory multiple myeloma, according to a phase 3 trial.

After receiving pelvic radiotherapy, cancer survivors could live with low-grade chronic inflammation for up to 20 years post-treatment, according to an expert.

CURE shares photos from patients with cancer who posted their animals or pets that took the role of a support system during cancer.

When mentioning “breast cancer” in a story about my college experience is not allowed, I considered alternatives to the medical term that describes my situation best.

Higher health care costs may be related to the stages of melanoma, especially because of the increasing prices of treatments, according to an expert.

An expert sat down with CURE® and discussed how stem cells are collected before a patient with myeloma undergoes a stem cell transplant.

Patients with Lynch syndrome who partake in regular and aerobic exercise can reduce their chances of receiving a diagnosis of colorectal cancer.

Patients with lung cancer undergoing anatomic lung resections often had one day home return after completing the surgery, but those with a lower socioeconomic status were less likely to leave the hospital the day after surgery.

I knew virtually nothing about cancer until I became a caregiver for my aunt Carolyn, who died of colorectal cancer in 2000.

Interim results of a trial displayed promising results for patients with ovarian cancer treated with IMNN-01 with neoadjuvant chemotherapy and a PARP inhibitor.

Patients with multiple myeloma who are undergoing systemic treatment can see improvements from exercise, a recent study shows.

“Full-time mom, full-time hairdresser, full-time wife” Maggie Cambora, who received a diagnosis of acute myeloid leukemia in 2020, received a stem cell transplant.

The notion of ‘time toxicity’ causes patients with stage 4 melanoma to have less available time in their everyday lives because of appointments and treatments.

A phase 2 trial found that some patients with classical Hodgkin lymphoma saw a nearly 74% probability of second remission due to retreatment with Keytruda.

Battling the unforgiving foe: Cancer.

The PALLAS trial analyzed the impact of BMI in patients with early hormone receptor positive breast cancer.

The BRAF inhibitor AMB-1310 is currently being studied in both the United States and China for the treatment of patients with glioblastoma who are carrying the BRAF V600E mutation.

Treatment with the combination of Sarclisa, Kyprolis, Revlimid and Isa-KRd generated high rates of minimal residual disease negativity in patients with newly diagnosed, high-risk multiple myeloma, irrespective of transplant status.

Treatment combination of Lutathera and Sandostatin improved outcomes for patients with gastroenteropancreatic neuroendocrine tumors.

As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about the differences between genetic and genomic testing in breast cancer care.

As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about personalized therapy in breast cancer care.

As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about side effect management in breast cancer care.

As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about prognostic and predictive outcomes in breast cancer, and the options available as a result.